← Back to Search

Behavioural Intervention

Group vs Individual Interventions for HIV Prevention

Q: Do I meet the qualifications to join this research endeavor?

<p>In order to be accepted, individuals must have <a href="https://www.withpower.com/clinical-trials/hiv">HIV</a>/<a href="https://www.withpower.com/clinical-trials/aids">AIDS</a> and fall within the 18-45 year age bracket. Accordingly, approximately 424 participants will qualify for this clinical research study.</p>

N/A

Waitlist Available

Led By Bisola O. Ojikutu, MD, MPH

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages between 18 and 45

Cis-gender woman

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month and 6-months after intervention

Awards & highlights

Study Summary

This trial aims to reduce HIV diagnosis rates among African-born Black women in the US by adapting two HIV prevention interventions & testing their effectiveness with a randomized trial.

Who is the study for?

This trial is for HIV-negative, African-born Black or mixed-Black cis-gender women aged 18-45 living in Greater Boston Area or New York City. Participants must speak English or French and have had unprotected sex recently. Pregnant women, men, and transgender individuals cannot join.Check my eligibility

What is being tested?

The study tests two adapted HIV prevention interventions: 'Dada Kwa Dada' (DKD) for individual-level education and 'DADA' for group sessions. Both aim to increase condom use and PrEP uptake among participants to reduce HIV/STI incidence.See study design

What are the potential side effects?

Since the interventions involve educational activities rather than medical treatments, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 45 years old.

Select...

I am a cisgender woman.

Select...

I have had unprotected sex with a man in the past 3 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month and 6-months after intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month and 6-months after intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month and 6-months after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of participants who are willing to take PrEP in the next 12 months.

Proportion of participants who obtained PrEP prescriptions.

Proportion of participants who took PrEP through pill or injection.

+1 more

Secondary outcome measures

Proportion of participants who accepted HIV testing.

Proportion of participants who tested positive for STI.

Proportion of participants with intention to get tested for HIV in the next 6 months.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group-level interventionExperimental Treatment1 Intervention

Virtual group sessions

Group II: Individual-level interventionActive Control1 Intervention

Virtual one-on-one session

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Boston UniversityOTHER

454 Previous Clinical Trials

9,941,146 Total Patients Enrolled

The Fenway InstituteOTHER

14 Previous Clinical Trials

2,403 Total Patients Enrolled

RANDOTHER

137 Previous Clinical Trials

509,827 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the qualifications to join this research endeavor?

"In order to be accepted, individuals must have HIV/AIDS and fall within the 18-45 year age bracket. Accordingly, approximately 424 participants will qualify for this clinical research study."

Answered by AI

Are participants below the age of 25 accepted in this trial?

"This study only targets patients aged 18 to 45. Patients under the age of 18 must look towards 53 other medical trials, while those who are 65 or older have access to 177 studies."

Answered by AI

Are enrollees still being accepted for this clinical research?

"Clinicaltrials.gov offers evidence that recruiting for this medical trial has been suspended, with its first posting on October 25th 2023 and last update made in September 12th of the same year. Nonetheless, 230 other studies are currently enrolling participants at present."

Answered by AI

Recent research and studies

Frontiers in EndocrinologyJournal

A1C Underperforms as a Diagnostic Test in Africans Even in the Absence of Nutritional Deficiencies, Anemia and Hemoglobinopathies: Insight from the Africans in America Study

Briker, Sara M., Jessica Y. Aduwo, Regine Mugeni, Margrethe F. Horlyck-Romanovsky, Christopher W. DuBose, Lilian S. Mabundo, Thomas Hormenu, et al.. 2019. “A1C Underperforms as a Diagnostic Test in Africans Even in the Absence of Nutritional Deficiencies, Anemia and Hemoglobinopathies: Insight from the Africans in America Study”. Frontiers in Endocrinology. Frontiers Media SA. doi:10.3389/fendo.2019.00533.

BMC International Health and Human RightsJournal

Validation of the Condom Use Self-efficacy Scale in Ethiopia

Shaweno, Debebe, and Emebet Tekletsadik. 2013. “Validation of the Condom Use Self-efficacy Scale in Ethiopia”. BMC International Health and Human Rights. Springer Science and Business Media LLC. doi:10.1186/1472-698x-13-22.

BMC Health Services ResearchJournal

Acceptability of Healthcare Interventions: An Overview of Reviews and Development of a Theoretical Framework

Sekhon, Mandeep, Martin Cartwright, and Jill J. Francis. 2017. “Acceptability of Healthcare Interventions: An Overview of Reviews and Development of a Theoretical Framework”. BMC Health Services Research. Springer Science and Business Media LLC. doi:10.1186/s12913-017-2031-8.

clinicaltrials.govStudy